Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Ercolano

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Biological Chemistry|January 9, 2008
Characterization of NAD uptake in mammalian cellsRichard A Billington, Cristina Travelli, Emanuela Ercolano, et al.
Chemmedchem|February 6, 2008
Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvageUbaldina Galli, Emanuela Ercolano, Lorenzo Carraro, et al.
Acta Neuropathologica Communications|December 16, 2023
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomasLaurien L van de Weijer, Emanuela Ercolano, Ting Zhang, et al.
Cancer Research|December 2, 2021
Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in Merlin-Negative Schwannoma and MeningiomaEmmanuel A Maze, Bora Agit, Shona Reeves, et al.
International Journal of Molecular Sciences|January 12, 2021
Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I MeningiomasAgbolahan A Sofela, David A Hilton, Sylwia Ammoun, et al.
Ebiomedicine|June 25, 2025
Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomasMaryam Shah, Yeasmin Akther, Claire L Adams, et al.
Oncogene|September 26, 2024
Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumoursForam Dave, Kevin Herrera, Alex Lockley, et al.
Oncogene|August 23, 2024
Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumoursForam Dave, Kevin Herrera, Alex Lockley, et al.
Brain : a Journal of Neurology|September 23, 2022
Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningiomaLiyam Laraba, Lily Hillson, Julio Grimm de Guibert, et al.
The Journal of Clinical Investigation|April 22, 2020
HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasisMarta Palomo-Irigoyen, Encarni Pérez-Andrés, Marta Iruarrizaga-Lejarreta, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Biological Chemistry|January 9, 2008
Characterization of NAD uptake in mammalian cellsRichard A Billington, Cristina Travelli, Emanuela Ercolano, et al.
Chemmedchem|February 6, 2008
Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvageUbaldina Galli, Emanuela Ercolano, Lorenzo Carraro, et al.
Acta Neuropathologica Communications|December 16, 2023
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomasLaurien L van de Weijer, Emanuela Ercolano, Ting Zhang, et al.
Cancer Research|December 2, 2021
Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in Merlin-Negative Schwannoma and MeningiomaEmmanuel A Maze, Bora Agit, Shona Reeves, et al.
International Journal of Molecular Sciences|January 12, 2021
Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I MeningiomasAgbolahan A Sofela, David A Hilton, Sylwia Ammoun, et al.
Ebiomedicine|June 25, 2025
Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomasMaryam Shah, Yeasmin Akther, Claire L Adams, et al.
Oncogene|September 26, 2024
Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumoursForam Dave, Kevin Herrera, Alex Lockley, et al.
Oncogene|August 23, 2024
Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumoursForam Dave, Kevin Herrera, Alex Lockley, et al.
Brain : a Journal of Neurology|September 23, 2022
Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningiomaLiyam Laraba, Lily Hillson, Julio Grimm de Guibert, et al.
The Journal of Clinical Investigation|April 22, 2020
HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasisMarta Palomo-Irigoyen, Encarni Pérez-Andrés, Marta Iruarrizaga-Lejarreta, et al.
Pageof 2